FC-REGION VON IMMUNGLOBULIN G BINDENDES POLYPEPTID

Patent europeic · EP2977088 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2977088
Numer da la dumonda
EP15181524
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-03-2011
Publitgà
27-01-2016
Concedì
02-08-2017
La protecziun finescha il pli tard
06-03-2031
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
C07K 14/31 (2006.01)
C07K 16/06 (2006.01)
Prioritad
EP 10155835 08.03.2010
Derivà da
EP11707162
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  5. 07-01-2021

    Adressa midada

    Owner
    GE Healthcare BioProcess R&D AB, Björkgatan 30, 751 84 Uppsala, Sweden → Cytiva BioProcess R&D AB, Björkgatan 30, 751 84 Uppsala, Sweden

    Published in Swissreg on 07.01.2021

  6. 02-08-2017

    Concedì

    Published in Swissreg on 02.08.2017

Partidas

Possessur

Cytiva BioProcess R&D AB

Björkgatan 30, 751 84 Uppsala, SE

Inventur

ABRAHMSEN, Lars

16853 Bromma, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.